By the Numbers

Parsing market signals in the latest agency credit risk transfer

| July 23, 2021

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors.

If the market reception for the most recent agency credit risk transfer deal is any sign, the appetite for exposure to the consumer balance sheet is strong. The latest Freddie Mac deal involved some of the largest blocks of subordinate credit risk ever traded, attracted heavy investor demand and ended up trading at tighter spreads than initial talk. The deal was helped by a few tweaks to the CRT structure that drew in new investors and by optimism about the future of CRT under the new leadership at the Federal Housing Finance Agency.

Freddie Mac’s STACR 2021-DNA5 priced on July 19 and transferred risk on $71.39 billion of loans largely originated in November and December last year. Outside of STACR 2019-FTR3, which combined four other STACR deals, the 2021-DNA5 deal referenced the largest pool of risk ever transferred in program history. The deal also placed $1.186 billion of securities, including the largest B1 and B2 classes ever sold.

Despite its size, investor demand left most classes of the 2021-DNA5 transaction oversubscribed, with some classes oversubscribed by nearly 10 times. Spreads tightened from price talk across the structure, with the B1 class seeing the most. Talk on the B1 started at SOFR + 325-350 bp and ended with the class pricing at SOFR + 305 bp. Even then, the tranche was still more than six times oversubscribed. The M2 class started at SOFR + 175-185 bp but ultimately priced at SOFR + 165 bp and was nearly 10 times oversubscribed.

Beyond the strong bid, demand was broad. The deal drew 66 unique investors, according to Freddie Mac, the most in a STACR transaction since 2017. The B1 class alone drew 39 unique investors, the most for that class in a STACR deal ever.

A few structural changes and better ratings likely provided a substantial lift to investor demand. Freddie Mac sets a minimum credit enhancement required before the M1 class can get principal. This is often set above the point where the M1 detaches, requiring the reference pool to pay down before the M1 gets principal. In 2021-DNA5, the agency reduced the minimum credit enhancement threshold to the 2.0% detachment point on the M1 class, making the class open-pay at issuance and substantially shortening the weighted average life on sequential-pay M2 and B1 certificates. The M2 class ended up not only shorter, but carried an investment grade rating at issuance, which likely fueled greater investor demand. The B1 class was notched just below investment grade and, importantly, was ERISA eligible, potentially increasing demand for that bond as well.

Investors also arguably showed new optimism about the future of CRT. The prospects for future issuance dimmed under existing GSE capital rules put in place under former FHFA Director Mark Calabria. Those rules diluted the capital benefits associated with issuing CRT by roughly 50% compared to capital rules proposed in 2018. Under new FHFA leadership, one potential path that could drive CRT issuance higher sooner would be the possibility that FHFA could delay the implementation date of the new capital rule while the current one is under review by newly nominated leadership. There is existing comparable precedent for this as the Consumer Finance Protection Bureau delayed implementation of new Qualified Mortgage definitions and rules prior to implementation. If FHFA were able to delay implementation of the capital rules, the GSEs would likely revert to the Conservatorship Capital Framework in the interim. An adoption of the CCF would likely pave the way for increased CRT issuance sooner than would otherwise happen under a completely revised capital rule. And while newly appointed leadership at FHFA has not made any public statement with regards to their views on the value associated with the enterprises issuing CRT, its highly likely that they will have a more constructive view of the programs than former Director Calabria who was a public detractor of CRT. While not published by the former director, FHFA issued a report in May which offered a less than constructive view of the programs, calling into question the value of premiums paid versus losses covered by issuance along with a few other factors.

Chris Helwig

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2023 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.

The Library

Search Articles